SpringWorks Therapeutics Inc. (SWTX) prices 9.48M share offering at $29

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced today the pricing of an underwritten public offering of 9,482,758 shares of its common stock at a public offering price of $29.00 per share. All of the shares in the offering are being sold by SpringWorks. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $275.0 million. The offering is expected to close on or about December 7, 2023, subject to the satisfaction of customary closing conditions. In addition, SpringWorks has granted the underwriters a 30-day option to purchase up to an additional 1,422,413 shares of its common stock at the public offering price, less underwriting discounts and commissions.

Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Cowen and Company, LLC and Guggenheim Securities, LLC are acting as joint book-running managers for the offering.

You May Also Be Interested In

• IQM Quantum Computers lists on Nasdaq after SPAC merger closes
• Eos Energy updates terms for rights offering at $5.481 per unit
• Nutrabolt picks banks for IPO that could raise up to $1 billion - Reuters